3-Bromo-1H-pyrazolo[4,3-c]pyridine

Catalog No. :
ACEOTK936
CAS No. :
633328-88-8
Molecular Formula :
C6H4BrN3
Molecular Weight :
198.02

IUPAC Name:3-bromo-1H-pyrazolo[4,3-c]pyridine

3-Bromo-1H-pyrazolo[4,3-c]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$62.00Login to see priceIn stockInquiry
5g97%$271.00Login to see priceIn stockInquiry
10g97%$383.00Login to see priceIn stockInquiry
25g97%$765.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-1H-pyrazolo[4,3-c]pyridine
IUPAC Name3-bromo-1H-pyrazolo[4,3-c]pyridine
MDL No.MFCD11518973
Molecular FormulaC6H4BrN3
Molecular Weight198.02
SMILESBrC1=N[NH]C2=C1C=NC=C2
InChI KeyNUCFNMOPTGEHQA-UHFFFAOYSA-N
Synonym3-BROMO-1H-PYRAZOLO[4,3-C]PYRIDINE | 633328-88-8 | 3-bromo-2H-pyrazolo[4,3-c]pyridine | MFCD11518973 | DIISOOCTYLAZELATE | SCHEMBL4145343 | 3-Bromopyrazolo[4,3-c]pyridine | DTXSID00671931 | NUCFNMOPTGEHQA-UHFFFAOYSA-N | AKOS006323464 | CS-W008912 | FS-2880 | PB20592 | AC-23304 | SY0
CAS No.633328-88-8
PubChem CID45789669

Safety Data

Pictogram
Toxic
Signal Word
Gefahr
Hazard Statement(s)
H301
Precautionary Statement(s)
P264-P270-P301+P310+P330-P405-P501

Synthetic Route by SureRoute

1. ACEOTK936 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQMZV508 route compound structure diagram
    ACQMZV508271-52-3 In Stock
  4. Then
  5. ACEOTK936 route product structure diagram
    ACEOTK936633328-88-8 In Stock
Inquiry

2. ACEOTK936 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQMZV508 route compound structure diagram
    ACQMZV508271-52-3 In Stock
  4. Then
  5. ACEOTK936 route product structure diagram
    ACEOTK936633328-88-8 In Stock
Inquiry

Comments (0)